Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1828 publications

Exploring Treatments for Hepatic Epithelioid Hemangioendothelioma: A Subsegmental Bland Embolization Case Series With Review.

Exploring Treatments for Hepatic Epithelioid Hemangioendothelioma: A Subsegmental Bland Embolization Case Series With Review.

Journal: Cancer control : journal of the Moffitt Cancer Center
Published: October 17, 2025

A Case of Long-Term Complete Remission by Pembrolizumab＋Axitinib, Cabozantinib for Papillary Renal Cell Carcinoma with Metastasis

A Case of Long-Term Complete Remission by Pembrolizumab＋Axitinib, Cabozantinib for Papillary Renal Cell Carcinoma with Metastasis

Journal: Hinyokika kiyo. Acta urologica Japonica
Published: October 01, 2025

Renal Cell Carcinoma in Pregnancy With Breast Metastasis: A Case Report and Literature Review.

Renal Cell Carcinoma in Pregnancy With Breast Metastasis: A Case Report and Literature Review.

Journal: Cureus
Published: September 17, 2025

Development and validation of a novel risk stratification signature derived from migrasome and tumor microenvironment-related genes for molecular subtyping and improving clinical outcomes in head and neck squamous cell carcinoma.

Development and validation of a novel risk stratification signature derived from migrasome and tumor microenvironment-related genes for molecular subtyping and improving clinical outcomes in head and neck squamous cell carcinoma.

Journal: Annals of medicine
Published: September 10, 2025

Late cutaneous metastasis of clear-cell renal cell carcinoma to the lower eyelid five years after radical nephrectomy: A case report.

Late cutaneous metastasis of clear-cell renal cell carcinoma to the lower eyelid five years after radical nephrectomy: A case report.

Journal: Urology case reports
Published: September 06, 2025

Identifying Drug Combination Strategies for ZMYM2: FGFR1 Fusion Positive Leukemia.

Identifying Drug Combination Strategies for ZMYM2: FGFR1 Fusion Positive Leukemia.

Journal: Precision oncogenomics
Published: August 29, 2025

Response to letter Re: Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor.

Response to letter Re: Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor.

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 27, 2025

Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial.

Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial.

Journal: JAMA oncology
Published: August 14, 2025

Design, synthesis and biological evaluation of novel pyrazoline derivatives as dual EGFR/VEGFR-2 inhibitors for targeted cancer therapy.

Design, synthesis and biological evaluation of novel pyrazoline derivatives as dual EGFR/VEGFR-2 inhibitors for targeted cancer therapy.

Journal: Bioorganic chemistry
Published: July 30, 2025

Targeting PLOD2 induces epithelioid differentiation and improves therapeutic response in sarcomatoid renal cell carcinoma.

Targeting PLOD2 induces epithelioid differentiation and improves therapeutic response in sarcomatoid renal cell carcinoma.

Journal: Journal of advanced research
Published: July 18, 2025

Cost-Effectiveness Analysis of Toripalimab Plus Axitinib for Patients with Advanced Renal Cell Carcinoma in the United States.

Cost-Effectiveness Analysis of Toripalimab Plus Axitinib for Patients with Advanced Renal Cell Carcinoma in the United States.

Journal: Clinical drug investigation
Published: July 07, 2025

Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinoma.

Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinoma.

Journal: Cancer
Published: June 29, 2025
Showing 1-12 of 1,828

Last Updated: 10/31/2025